MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

Meeting: 2024 International Congress

Abstract Number: 1484

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Dystonia: Genetics, Neurobehavioral disorders

Category: Huntington's Disease

Objective: ​​​​​​Childhood-onset Huntington’s disease (HD) is a rare subset of HD with symptom-onset before the age of 18 years. We here detail the presenting movement disorder spectrum in seven cases of childhood-onset HD, evaluated between 2022-2024.

Background: HD in adulthood typically manifests with generalized and progressive chorea. In contrast, childhood-onset HD, which represents 3-10% of all cases, typically does not manifest chorea initially but rather presents with cognitive decline, behavioral dysregulation, epilepsy and a diverse spectrum of movement disorders. This presents distinct challenges in diagnosis and management.

Method: A combination of detailed clinical assessments, standardized video recording, HTT repeat expansion testing, and review of brain MRI findings.

Results: Where parental testing was possible, all cases had a positive family history of genetically confirmed HD. Within our cohort of 7 patients, all had early cognitive or behavioral symptoms preceding motor symptoms. The most common amongst these included cognitive decline, ADHD, ASD, aggression, sleep disorder, and anxiety. The movement disorder spectrum upon initial presentation included dystonia, myoclonus, Parkinsonism, and chorea. Notably, all patients presented with severe and progressive dysarthria. Although a negative correlation (r = -0.56) between length of CAG repeats and age at motor symptom onset was noted, it did not reach statistical significance. Of the 6 available imaging studies, all showed significant volume loss of the caudate and putamen.

Conclusion: Our findings underscore the importance of recognizing neurodevelopmental symptoms as an early manifestation of childhood-onset HD. The spectrum of presenting movement disorders is broad and evolves throughout the disease course. Dedicated testing for HD should be considered in children presenting with neurodevelopmental concerns and movement disorders, particularly in the setting of a positive family history or unavailability of parental testing. Given the heterogeneity of presenting symptoms, a multidisciplinary approach should be taken with the management of these patients, including early involvement of OT, PT, SLP, and specialties such as psychiatry, neurology, genetics, and palliative care.

Brain MRIs of patient cohort

Brain MRIs of patient cohort

To cite this abstract in AMA style:

K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari. The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/the-spectrum-of-presenting-phenotypes-in-childhood-onset-huntingtons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-spectrum-of-presenting-phenotypes-in-childhood-onset-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley